Chelation Therapy

"Chelation Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Therapy of heavy metal poisoning using agents which sequester the metal from organs or tissues and bind it firmly within the ring structure of a new compound which can be eliminated from the body.

Descriptor ID	D015913
MeSH Number(s)	E02.319.155
Concept/Terms	Chelation Therapy Chelation Therapy Therapy, Chelation Chelation Therapies Therapies, Chelation

Below are MeSH descriptors whose meaning is more general than "Chelation Therapy".

Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
Therapeutics [E02]
Drug Therapy [E02.319]
Chelation Therapy [E02.319.155]

Below are MeSH descriptors whose meaning is more specific than "Chelation Therapy".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Chelation Therapy" by people in this website by year, and whether "Chelation Therapy" was a major or minor topic of these publications.

Bar chart showing 2 publications over 2 distinct years, with a maximum of 1 publications in 2017 and 2022

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2017	1	0	1
2022	1	0	1

Below are the most recent publications written about "Chelation Therapy" by people in Profiles.

Ravalli F, Vela Parada X, Ujueta F, Pinotti R, Anstrom KJ, Lamas GA, Navas-Acien A. Chelation Therapy in Patients With Cardiovascular Disease: A Systematic Review. J Am Heart Assoc. 2022 03 15; 11(6):e024648.

View in: PubMed
Griswold MK, Nordberg A, Babu KM, Boyer EW, Chai PR. Accidental copper sulfate toxicity after flame colorant ingestion. Clin Toxicol (Phila). 2017 09; 55(8):943-945.

View in: PubMed
Walter PB, Porter J, Evans P, Kwiatkowski JL, Neufeld EJ, Coates T, Giardina PJ, Grady RW, Vichinsky E, Olivieri N, Trachtenberg F, Alberti D, Fung E, Ames B, Higa A, Harmatz P. Increased leucocyte apoptosis in transfused ?-thalassaemia patients. Br J Haematol. 2013 Feb; 160(3):399-403.

View in: PubMed
Trachtenberg F, Vichinsky E, Haines D, Pakbaz Z, Mednick L, Sobota A, Kwiatkowski J, Thompson AA, Porter J, Coates T, Giardina PJ, Olivieri N, Yamashita R, Neufeld EJ. Iron chelation adherence to deferoxamine and deferasirox in thalassemia. Am J Hematol. 2011 May; 86(5):433-6.

View in: PubMed
Mednick L, Yu S, Trachtenberg F, Xu Y, Kleinert DA, Giardina PJ, Kwiatkowski JL, Foote D, Thayalasuthan V, Porter JB, Thompson AA, Schilling L, Quinn CT, Neufeld EJ, Yamashita R. Symptoms of depression and anxiety in patients with thalassemia: prevalence and correlates in the thalassemia longitudinal cohort. Am J Hematol. 2010 Oct; 85(10):802-5.

View in: PubMed
Wood JC, Glynos T, Thompson A, Giardina P, Harmatz P, Kang BP, Paley C, Coates TD. Follow-up report on the 2-year cardiac data from a deferasirox monotherapy trial. Am J Hematol. 2010 Oct; 85(10):818-9.

View in: PubMed
Galanello R, Agus A, Campus S, Danjou F, Giardina PJ, Grady RW. Combined iron chelation therapy. Ann N Y Acad Sci. 2010 Aug; 1202:79-86.

View in: PubMed
Counter SA, Buchanan LH, Ortega F. Neurophysiologic and neurocognitive case profiles of Andean patients with chronic environmental lead poisoning. J Toxicol Environ Health A. 2009; 72(19):1150-9.

View in: PubMed
Harmatz P, Grady RW, Dragsten P, Vichinsky E, Giardina P, Madden J, Jeng M, Miller B, Hanson G, Hedlund B. Phase Ib clinical trial of starch-conjugated deferoxamine (40SD02): a novel long-acting iron chelator. Br J Haematol. 2007 Aug; 138(3):374-81.

View in: PubMed
Vogiatzi MG, Autio KA, Mait JE, Schneider R, Lesser M, Giardina PJ. Low bone mineral density in adolescents with beta-thalassemia. Ann N Y Acad Sci. 2005; 1054:462-6.

View in: PubMed

People

Explore

Similar Concepts

Top Journals